MedPath

Valsartan

Valsartan Tablets, USP Rx Only These highlights do not include all the information needed to use VALSARTAN TABLETS safely and effectively. See full prescribing information for VALSARTAN TABLETS. Initial U.S. Approval: 1996

Approved
Approval ID

0878f27e-5368-c93f-e063-6394a90a1086

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 24, 2023

Manufacturers
FDA

AvPAK

DUNS: 832926666

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Valsartan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50268-746
Application NumberANDA203311
Product Classification
M
Marketing Category
C73584
G
Generic Name
Valsartan
Product Specifications
Route of AdministrationORAL
Effective DateOctober 24, 2023
FDA Product Classification

INGREDIENTS (10)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
VALSARTANActive
Quantity: 40 mg in 1 1
Code: 80M03YXJ7I
Classification: ACTIB

Valsartan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50268-747
Application NumberANDA203311
Product Classification
M
Marketing Category
C73584
G
Generic Name
Valsartan
Product Specifications
Route of AdministrationORAL
Effective DateOctober 24, 2023
FDA Product Classification

INGREDIENTS (10)

HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
VALSARTANActive
Quantity: 80 mg in 1 1
Code: 80M03YXJ7I
Classification: ACTIB

Valsartan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50268-749
Application NumberANDA203311
Product Classification
M
Marketing Category
C73584
G
Generic Name
Valsartan
Product Specifications
Route of AdministrationORAL
Effective DateOctober 24, 2023
FDA Product Classification

INGREDIENTS (12)

HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
VALSARTANActive
Quantity: 320 mg in 1 1
Code: 80M03YXJ7I
Classification: ACTIB
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT

Valsartan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50268-748
Application NumberANDA203311
Product Classification
M
Marketing Category
C73584
G
Generic Name
Valsartan
Product Specifications
Route of AdministrationORAL
Effective DateOctober 24, 2023
FDA Product Classification

INGREDIENTS (11)

FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
VALSARTANActive
Quantity: 160 mg in 1 1
Code: 80M03YXJ7I
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Valsartan - FDA Drug Approval Details